Seres Therapeutics Inc (MCRB) stock is down -84.61% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MCRB stock a score of 29 out of a possible 100.
That rank is influenced by a short-term technical score of 0. MCRB's rank also includes a long-term technical score of 0.
MCRB has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on MCRB!
Seres Therapeutics Inc (MCRB) stock has fallen -6.92% while the S&P 500 has gained 0.18% as of 9:50 AM on Monday, Nov 6. MCRB is down -$0.09 from the previous closing price of $1.30 on volume of 627,076 shares. Over the past year the S&P 500 has gained 14.70% while MCRB is down -84.61%. MCRB lost -$1.13 per share in the over the last 12 months.
Click Here to get the full Stock Report for Seres Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
